Venture

Inspiration Biopharmaceuticals Inc

Latest Form D 2011-03-29
  • CIK 1428124
  • State CA
  • Biotechnology
  • 1 Form D offering since 2009-07-23
Total sold
$248M
across its one offering
Rounds
1
Form D offerings since 2009-07-23
Latest round
$248M
2009-07-23 · 021-115176
Investors
4
on the latest round

Connected

named in its Form D filings

Round timeline

amount sold · by first filed
2009-07-23 · $248M
  1. 2009-07-23$248M021-115176

Hover a dot or row, or tab through the dots · bars scaled to the largest round ($248M)

Form D offerings

One line per offering, amendments folded in, newest first

Form D offerings
FileFirst filedLatestSoughtSoldInvestorsExemptions
021-115176First filed2009-07-23Latest2011-03-29Sought$372MSold$248MInvestors4Exemptions506
Who backs Inspiration Biopharmaceuticals Inc, inferred from co-filings, and every Form D as filedSee plans

People

Named in Item 3 of its latest Form D, filed 2011-03-29

Related persons
NameRelationshipClarification
John R. TaylorRelationshipDirector, PromoterClarificationCo-Founder of Inspiration Biopharmaceuticals, Inc., and Chairman of the Board of Directors.
Scott D. MartinRelationshipDirector, PromoterClarificationCo-Founder of Inspiration Biopharmaceuticals, Inc., and Member of the Board of Directors.
Michael J. GiffithRelationshipExecutive Officer, DirectorClarificationPresident and Chief Executive Officer of Inspiration Bipharmaceuticals, Inc., and Member of the Board of Directors.
Gordon H. BusenbarkRelationshipExecutive OfficerClarificationChief Finanacial Officer, Secretary, and Treasurer.
Barry R. FrankelRelationshipDirectorClarificationMember of the Board of Directors.
Stephen R. Evans-FrekeRelationshipDirectorClarificationMember of the Board of Directors.
Andrew GrethleinRelationshipExecutive OfficerClarificationChief Operating Officer.
Gerard PicotRelationshipDirectorClarificationMember of the Board of Directors.
Karen DawesRelationshipDirectorClarificationMember of the Board of Directors.

Sales compensation

Named in Item 12 of its Form D filings

Sales compensation recipients
RecipientCRDBroker-dealerOfferings
Healthios, Inc.CRD—Broker-dealer—Offerings1

Facts

As its latest Form D states them

Industry
Biotechnology
State
California (CA)
Exemptions
Rule 506
First filed
2009-07-23
Latest filing
2011-03-29
Minimum investment
$435K

Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.

  • Inferred investors — the funds and firms behind it, from co-filings and shared people
  • Every Form D and amendment as filed, with what each one stated
  • Its rounds in sequence: the gap between them and whether they grew
  • Everyone its filings name, linked to their other companies, with its addresses and phone numbers

Part of the Venture plan — $140/mo at launch pricing ($350 list)

See plans

External link: SEC Filings ↗